Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis-Reference-Cited by-全球学者库

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

Published:2019-10 Issue:10 Volume:20 Page:1395-1408
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Antonia Scott J,Borghaei Hossein,Ramalingam Suresh S,Horn Leora,De Castro Carpeño Javier,Pluzanski Adam,Burgio Marco A,Garassino Marina,Chow Laura Q M,Gettinger Scott,Crinò Lucio,Planchard David,Butts Charles,Drilon Alexander,Wojcik-Tomaszewska Joanna,Otterson Gregory A,Agrawal Shruti,Li Ang,Penrod John R,Brahmer Julie

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. SEER Cancer Statistics Review;Noone,1975

3. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

4. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study;Scientific Reports;2024-01-28

2. Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors;Respiratory Investigation;2024-01

3. Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma;American Journal of Otolaryngology;2024-01

4. The efficacy of immune checkpoint inhibitors following discontinuation for long‐term response or toxicity in advanced or metastatic non‐small‐cell lung cancers: A retrospective study;Health Science Reports;2024-01

5. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases;Internal Medicine;2024